NCT06878742View on ClinicalTrials.gov

Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Infant, Premature, DiseasesCirculatory and Respiratory Physiological Phenomena
Interventions
DRUG

Intravenous dobutamine 5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 5 mcg/kg/min.

DRUG

Intravenous dobutamine 7.5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 7.5 mcg/kg/min.

DRUG

Intravenous dobutamine 10 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 10 mcg/kg/min.

DRUG

Intravenous dobutamine 12.5 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 12.5 mcg/kg/min.

DRUG

Intravenous dobutamine 15 mcg/kg/min

Intravenous dobutamine will be administered at a dose of 15 mcg/kg/min.

Trial Locations (3)

28002

RECRUITING

Hospital Universitario Quironsalud, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28046

RECRUITING

Hospital Universitario La Paz, Madrid

All Listed Sponsors
lead

Instituto de Investigación Hospital Universitario La Paz

OTHER